Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02326539
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
You can sort the columns by Ligand, Ligand name, PDB and Tanimoto.
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
---|---|---|---|---|---|
Ligand | Ligand name | Chain | PDB | Tanimoto | Ligand in PDB |
NSK | N-SUCCINYL LYSINE | A | 2P8B | 0.73 | |
097 | (2S,3R)-N~4~-[(1S)-2,2-dimethyl- 1-(methylcarbamoyl)propyl]-N~1~,2- dihydroxy-3-(2-methylpropyl)butanediamide | A,B | 3HY7 | 0.74 | |
097 | (2S,3R)-N~4~-[(1S)-2,2-dimethyl- 1-(methylcarbamoyl)propyl]-N~1~,2- dihydroxy-3-(2-methylpropyl)butanediamide | A,B | 2JIH | 0.74 | |
097 | (2S,3R)-N~4~-[(1S)-2,2-dimethyl- 1-(methylcarbamoyl)propyl]-N~1~,2- dihydroxy-3-(2-methylpropyl)butanediamide | A | 1R55 | 0.74 | |
MNL | 4,N-DIMETHYLNORLEUCINE | C | 1CWC | 0.73 | |
TMD | (6,7-DIHYDRO)4-[(E)-BUTENYL]-4,N- DIMETHYL-THREONINE | C | 1CWK | 0.73 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 3EMY | 0.76 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 2H6T | 0.76 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1LS5 | 0.76 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1SME | 0.76 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,C | 1W6I | 0.76 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1XDH | 0.76 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 2QZX | 0.76 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A | 1IZE | 0.76 | |
IHN | N-(3-methylbutanoyl)-L-valyl-N- [(1R,2R)-4-{[(1R)-2-({(1R)-1-[(1R)- 2-carboxy-1-hydroxyethyl]-3-methylbutyl}amino)- 1-methyl-2-oxoethyl]amino}-2-hydroxy- 1-(2-methylpropyl)-4-oxobutyl]- L-valinamide | A,B | 1M43 | 0.76 | |
REZ | (2R)-2-AMINO-7-{[(1R)-1-CARBOXYETHYL]AMINO}- 7-OXOHEPTANOIC ACID | A,B | 2J9P | 0.73 | |
REZ | (2R)-2-AMINO-7-{[(1R)-1-CARBOXYETHYL]AMINO}- 7-OXOHEPTANOIC ACID | A,B,C,D | 2VGK | 0.73 | |
074 | [PROPYLAMINO-3-HYDROXY-BUTAN-1,4- DIONYL]-ISOLEUCYL-PROLINE | A | 1QDQ | 0.74 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 2BJS | 0.73 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1QJE | 0.73 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1BK0 | 0.73 | |
ACV | L-D-(A-AMINOADIPOYL)-L-CYSTEINYL- D-VALINE | A | 1BLZ | 0.73 | |
ATI | N-(3-AMINO-2-HYDROXY-5-METHYLHEXANOYL)VALYLVALYLASPARTIC ACID | A | 1Y0Y | 0.73 | |
DLS | DI-ACETYL-LYSINE | A,B,C,D,E,F | 1FVM | 0.76 | |
SLA | (3S,4R)-3-hydroxy-2-[(1S)-1-hydroxy- 2-methylpropyl]-4-methyl-5-oxo- D-proline | H,K,V,Y | 3DY4 | 0.72 | |
ACW | D-(L-A-AMINOADIPOYL)-L-CYSTEINYL- B-METHYL-D-CYCLOPROPYLGLYCINE | B | 2IVI | 0.71 | |
U17 | METHYL N-[(2S,3R)-3-AMINO-2-HYDROXYHEPTANOYL]- L-SERYL-L-LEUCINATE | A | 2GGB | 0.77 | |
FEB | N~2~-[(3R)-3-hydroxydodecanoyl]- L-asparaginyl-N~1~-[(1S)-1-(hydroxymethyl)- 3-methylbutyl]-L-glutamamide | 2,H,K,N,V,Y | 3D29 | 0.71 | |
HCG | DELTA-(L-ALPHA-AMINOADIPOYL)-L- CYSTEINYL-GLYCINE | A | 1W03 | 0.72 | |
HCG | DELTA-(L-ALPHA-AMINOADIPOYL)-L- CYSTEINYL-GLYCINE | A | 1W04 | 0.72 | |
AR9 | (2R,4S)-N-butyl-4-[(2S,5S,7R)-2,7- dimethyl-3,15-dioxo-1,4-diazacyclopentadecan- 5-yl]-4-hydroxy-2-methylbutanamide | A,B,C | 3DV1 | 0.71 | |
CLG | 2-AMINO-6-[2-(2-AMINOOXY-ACETYLAMINO)- ACETYLAMINO]-HEXANOIC ACID | A,B | 1K09 | 0.78 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1PPP | 0.74 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1PE6 | 0.74 | |
E6C | N-[1-HYDROXYCARBOXYETHYL-CARBONYL]LEUCYLAMINO- 2-METHYL-BUTANE | A | 1ITO | 0.74 | |
PYH | N~6~-{[(2R,3R)-3-METHYL-3,4-DIHYDRO- 2H-PYRROL-2-YL]CARBONYL}-L-LYSINE | A | 2ZCE | 0.71 | |
LLY | NZ-(DICARBOXYMETHYL)LYSINE | A,B | 1UCW | 0.75 | |
CCL | N~6~-[(CYCLOPENTYLOXY)CARBONYL]- D-LYSINE | A | 2Q7G | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2B4D | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2OD9 | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,P,Q | 2DVR | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,P,Q | 2DVS | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,P,Q | 2DVQ | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,D | 2OT7 | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2B5G | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A | 2GIV | 0.72 | |
ALY | N(6)-ACETYLLYSINE | B | 2RNY | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A | 1JSP | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B,I,L | 2V5W | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,D | 3D4B | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,D | 2OQ6 | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2R0Y | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A | 3CZ7 | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A | 1JM4 | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2H4H | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2J6V | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2R10 | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1YC5 | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,D | 2OX0 | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2H2G | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,D | 2H4F | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A | 2OU2 | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1S5P | 0.72 | |
ALY | N(6)-ACETYLLYSINE | B | 2RNW | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A | 3D35 | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2OD2 | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A | 2ZFN | 0.72 | |
ALY | N(6)-ACETYLLYSINE | C,D | 2C1J | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2QQG | 0.72 | |
ALY | N(6)-ACETYLLYSINE | B | 2RNX | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1MA3 | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2H2H | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A | 2I2Z | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2OD7 | 0.72 | |
ALY | N(6)-ACETYLLYSINE | P | 1E6I | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1SZC | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B,C,D,I,J, K,L | 3EWF | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2H2D | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1Q1A | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 1SZD | 0.72 | |
ALY | N(6)-ACETYLLYSINE | Q,R | 2E3K | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A | 2OZU | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B | 2QQF | 0.72 | |
ALY | N(6)-ACETYLLYSINE | A,B,C | 2R0V | 0.72 | |
REX | GLYCYL-L-ALPHA-AMINO-EPSILON-PIMELYL- D-ALANYL-D-ALANINE | A | 1IKG | 0.75 | |
CLH | 2-AMINO-6-[2-(2-OXO-ACETYLAMINO)- ACETYLAMINO]-HEXANOIC ACID | A,B | 1K09 | 0.79 | |
SLR | (3R,4R)-3-hydroxy-2-[(1S)-1-hydroxy- 2-methylpropyl]-4-methyl-5-oxo- D-proline | K,Y | 3DY3 | 0.72 | |
LNT | N-[(2S)-2-amino-1,1-dihydroxy-4- methylpentyl]-L-threonine | A,B,C | 3B80 | 0.76 | |
LNT | N-[(2S)-2-amino-1,1-dihydroxy-4- methylpentyl]-L-threonine | A,B,C | 3B7V | 0.76 | |
BCV | D-(L-A-AMINOADIPOYL)-L-CYSTEINYL- D-CYCLOPROPYLGLYCINE | A | 2IVJ | 0.72 | |
W05 | DELTA-(L-ALPHA-AMINOADIPOYL)-L- CYSTEINYL-D-ALANINE | A | 1W05 | 0.71 | |
W05 | DELTA-(L-ALPHA-AMINOADIPOYL)-L- CYSTEINYL-D-ALANINE | A | 1W06 | 0.71 | |
5FP | 5,5,5-TRIFLUORO-3-HYDROXY-4-[2- (5,5,5-TRIFLUORO-3-HYDROXY-4-{3- METHYL-2-[3-METHYL-2-(3-METHYL- BUTYRYLAMINO)-BUTYRYLAMINO]-BUTYRYLAMINO}- PENTANOYLAMINO)-PROPIONYLAMINO]- PENTANOIC ACID | A,B | 1XE6 | 0.71 | |
IVS | 3-HYDROXY-6-METHYL-4-(3-METHYL- 2-(3-METHYL-2-(3-METHYL-BUTYRYLAMINO)- BUTYRYLAMINO)-BUTYRYLAMINO)-HEPTANOIC ACID ETHYL ESTER | A,B | 1ME6 | 0.74 | |
VB1 | N^6^-[(1R)-2-{[(1S)-1-carboxypropyl]amino}- 2-oxo-1-(sulfanylmethyl)ethyl]- 6-oxo-L-lysine | A | 2VBP | 0.71 | |
C6L | N-hexanoyl-L-homoserine | A | 3DHA | 0.75 | |
C6L | N-hexanoyl-L-homoserine | A | 3DHB | 0.75 | |
MCL | NZ-(1-CARBOXYETHYL)-LYSINE | A,B | 1O5K | 0.73 | |
MCL | NZ-(1-CARBOXYETHYL)-LYSINE | A,B | 3CPR | 0.73 | |
MCL | NZ-(1-CARBOXYETHYL)-LYSINE | A,B | 2VC6 | 0.73 | |
REY | GLYCYL-L-ALPHA-AMINO-EPSILON-PIMELYL- D-ALANINE | A | 1IKI | 0.76 | |
5FE | 5,5,5-TRIFLUORO-3-HYDROXY-4-[2- (5,5,5-TRIFLUORO-3-HYDROXY-4-{3- METHYL-2-[3-METHYL-2-(3-METHYL- BUTYRYLAMINO)-BUTYRYLAMINO]-BUTYRYLAMINO}- PENTANOYLAMINO)-PROPIONYLAMINO]- PENTANOIC ACID METHYL ESTER | A,B | 1XE5 | 0.7 |